SeekPeptides members have access to even more detailed protocol builders, but this guide covers everything you need to make an informed decision about your starting dose, your escalation timeline, and your maintenance target
By considering your age, lifestyle, and objectives, we provide practical nutritional advice that helps you achieve efficient outcomes
This is mainly because of the reported weight loss While GLP-1 medications Zepbound and This rapid increase in users of GLP-1 drugs has caused Now, a new study published in Annals of Internal Medicine , reports that among the approximately 1 million new GLP-1 medication users identified between 2011 to 2023, there was a twofold increase in GLP-1 medication users who do not have type 2 diabetes but do have a body mass index (BMI) of 30 killograms per square meter (kg/m 2 ) or greater, and in people with a BMI of 27 to 30 kg/m 2 and an obesity-related The researchers also found that the proportion of users of GLP-1 medications without FDA-approved indications rose from 0.21% in 2019 to 0.37% in 2023
GLP-1, along with other appetite-regulating peptides, modulate various aspects of addiction processes
GLP-1 microdosing aligns with this philosophy by: Shifting from Reactive to Proactive Care Instead of waiting for full-blown diabetes or obesity to develop, microdosing allows us to intervene upstream, potentially preventing disease progression before it fully takes hold
Instead, optimizing sleep, stress management, and recovery should be prioritized alongside the current stack
